Provexis (LSE:PXS) Gross Profit : £0.28 Mil (TTM As of Sep. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Provexis Gross Profit?

Provexis's gross profit for the six months ended in Sep. 2023 was £0.14 Mil. Provexis's gross profit for the trailing twelve months (TTM) ended in Sep. 2023 was £0.28 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Provexis's gross profit for the six months ended in Sep. 2023 was £0.14 Mil. Provexis's Revenue for the six months ended in Sep. 2023 was £0.39 Mil. Therefore, Provexis's Gross Margin % for the quarter that ended in Sep. 2023 was 35.57%.

Provexis had a gross margin of 35.57% for the quarter that ended in Sep. 2023 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of Provexis was 95.61%. The lowest was 46.75%. And the median was 89.66%.

Warning Sign:

Provexis PLC gross margin has been in long-term decline. The average rate of decline per year is -2.1%.

Provexis Gross Profit Historical Data

The historical data trend for Provexis's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Provexis Gross Profit Chart

Provexis Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Gross Profit

Get a 7-Day Free Trial

0.27

0.31

0.46

0.38

0.29

Provexis Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Gross Profit	Get a 7-Day Free Trial															0.19	0.19	0.15	0.14	0.14

Competitive Comparison of Provexis's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Provexis's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Provexis's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Provexis's Gross Profit distribution charts can be found below:

* The bar in red indicates where Provexis's Gross Profit falls into.

Provexis Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Provexis's Gross Profit for the fiscal year that ended in Mar. 2023 is calculated as

Gross Profit (A: Mar. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	0.39	-	0.096
	=	0.29

Provexis's Gross Profit for the quarter that ended in Sep. 2023 is calculated as

Gross Profit (Q: Sep. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	0.388	-	0.25
	=	0.14

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.28 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Provexis's Gross Margin % for the quarter that ended in Sep. 2023 is calculated as

Gross Margin % (Q: Sep. 2023 )	=	Gross Profit (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	0.14	/	0.388
	=	35.57 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Provexis (LSE:PXS) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Provexis had a gross margin of 35.57% for the quarter that ended in Sep. 2023 => Competition eroding margins

Provexis Gross Profit Related Terms

Thank you for viewing the detailed overview of Provexis's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Provexis (LSE:PXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Provexis PLC (LSE:PXS) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

PXS.GB:UK

Address

2 Blagrave Street, I Ford, Reading, Berkshire, GBR, RG1 1AZ

Website

https://www.provexis.com

Provexis PLC is a British food company. It is engaged in developing and licensing the Fruitflow, which is a patented, natural, breakthrough ingredient which helps with platelet aggregation. Fruitflow reduces the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can result in heart attack and stroke. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats.